Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 9Withdrawn 3Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, B-Cell, Marginal Zone 1Gastroesophageal Reflux 1Barrett Esophagus 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lansoprazole × Clear all
NCT04400136 2020-05-22

PPI Therapy Impact on GERD After Sleeve Gastrectomy

University of Roma La Sapienza

Phase EARLY_PHASE1 Unknown
45 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT02388581 2016-03-25

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

National Health Research Institutes, Taiwan

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡